Epidermal Growth Factor Recept
or Peptide (985-996)-Epidermal Growth Factor Receptor Peptide (985-996)- ￥33
- APExBIO
- 美国
- APE-A1021-1
- 2025年07月14日
企业认证
相关产品推荐更多 >
盐酸羟嗪,Hydroxyzine Dihydrochloride,CAS：2192-20-3
￥11
Azidobutyric acid NHS ester-Azidobutyric acid NHS ester
￥33![VEGFR-2 (Tyr-801)[保守位点]，磷酸化特异性/VEGFR-2 (Tyr-801)[conserved site], phospho-specific](https://img1.dxycdn.com/2021/1217/260/7468014372190031253-14.jpg!wh200)
VEGFR-2 (Tyr-801)[保守位点]，磷酸化特异性/VEGFR-2 (Tyr-801)[conserved site], phospho-specific
询价
Recombinant Bifunctional ligase/repressor BirA-Recombinant Bifunctional ligase/repressor BirA
￥33
二氢吲哚菁绿钠盐90％,Dihydro Indocyanine Green Sodium Salt 90%,CAS：1132970-51-4
￥11
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
储存于-20 ° C
- 保质期：
1年
- 英文名：
Epidermal Growth Factor Receptor Peptide (985-996)
- 库存：
100
- 供应商：
艾美捷科技
- CAS号：
无
- 规格：
1mg
Epidermal Growth Factor Receptor Peptide (985-996)，Epidermal Growth Factor Receptor Peptide (985-996)，Epidermal Growth Factor Receptor Peptide (985-996),Epidermal Growth Factor Receptor Peptide (985-996)
Epidermal Growth Factor Receptor Peptide (985-996)-Epidermal Growth Factor Receptor Peptide (985-996)
产品货号：APE-A1021-1
产品规格：1mg
表皮生长因子受体多肽（985-996）
Cancer Biology|Cancer Biology Peptides
Epidermal Growth Factor Receptor Peptide (985-996)-Epidermal Growth Factor Receptor Peptide (985-996)储存于-20 ° C
点击：Epidermal Growth Factor Receptor Peptide (985-996)-Epidermal Growth Factor Receptor Peptide (985-996)查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论，请点击查看艾美捷特色产品中心。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Signaling by Growth Factor Receptors
Growth factor receptors (GFRs) represent a subset of a large class of proteins that serve as extracellular environment sensors of the cell. They are single transmembrane proteins with an extracellular ligand-binding domain (LBD
Modulation of Growth Factor Receptor Expression by Irradiation for Immunotoxin Targeting
Immunotoxins, characterized by tumor-specific cytotoxicity and high potency, have been developed as one of the new promising treatment modalities for primary malignant brain tumors (1 –3 ). Fusion toxins bind to the cell-surface receptor
Microsatellite Analysis of the Insulin-Like Growth Factor II Receptor in Colorectal Carcinomas
The insulin-like growth factor II (IGFII) growth control pathway is comprised of three major components: IGFII ligand, insulin-like growth factor I receptor (IGFIR), and insulin-like growth factor II receptor (IGFIIR ). IGFIR and IGFIIR work
技术资料暂无技术资料 索取技术资料
